Clinical Trial Update: Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

Phase 3 trial update examining the efficacy and safety of sirolimus in active systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: ACTIVE_NOT_RECRUITING